This is a multicenter, non-interventional, cohort study in pediatric patients with active juvenile enthesitis-related or psoriatic arthritis
Written informed consent and legal representative's permission for study participation obtained prior to beginning of participation in the study.
Age ≥6 to <18 years old.
Peripheral arthritis and enthesitis, or
Arthritis or enthesitis, plus ≥ 3 months of inflammatory back pain and sacroiliitis on imaging, or
Known or suspected severe hypersensitivity for secukinumab, formulation excipients, or injection device components (i.e., latex).
Chronic recurrent infections.
Clinically significant infection exacerbation, including active tuberculosis.
Age <6 years or ≥18 years.